The prognostic significance of [
Interpretation criteria
Italian Myeloma criteria for PET Use (IMPeTUs)
Multiple myeloma
[18F]FDG PET/CT
Journal
EJNMMI research
ISSN: 2191-219X
Titre abrégé: EJNMMI Res
Pays: Germany
ID NLM: 101560946
Informations de publication
Date de publication:
09 Oct 2021
09 Oct 2021
Historique:
received:
13
07
2021
accepted:
23
09
2021
entrez:
10
10
2021
pubmed:
11
10
2021
medline:
11
10
2021
Statut:
epublish
Résumé
[ Forty-seven patients with newly diagnosed MM underwent [ Median follow-up from baseline and follow-up PET/CT were 85.1 months and 76.7 months, respectively. The number of focal, [ Several parameters utilized in IMPeTUs predict PFS in MM patients, suggesting the potentially significant role of the new criteria in patient stratification and response assessment. Additional studies are warranted for the further evaluation of IMPeTUs in the direction of establishment of robust cut-off values with a prognostic significance in the disease.
Identifiants
pubmed: 34628525
doi: 10.1186/s13550-021-00846-y
pii: 10.1186/s13550-021-00846-y
pmc: PMC8502185
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100Informations de copyright
© 2021. The Author(s).
Références
Leukemia. 2020 Jul;34(7):1853-1865
pubmed: 32034285
Br J Haematol. 1998 Sep;102(5):1115-23
pubmed: 9753033
J Clin Oncol. 2005 May 20;23(15):3412-20
pubmed: 15809451
Eur J Haematol. 2010 Aug;85(2):114-9
pubmed: 20477863
Molecules. 2019 Dec 29;25(1):
pubmed: 31905752
Bone Marrow Transplant. 2001 Jun;27(11):1215-7
pubmed: 11551034
Blood. 2017 Jul 6;130(1):30-34
pubmed: 28432222
Br J Haematol. 2003 Jun;121(5):749-57
pubmed: 12780789
Clin Cancer Res. 2015 Oct 1;21(19):4384-90
pubmed: 26078390
Blood. 2009 Sep 3;114(10):2068-76
pubmed: 19443657
Am Soc Clin Oncol Educ Book. 2016;35:e407-17
pubmed: 27249748
Contrast Media Mol Imaging. 2018 Jul 30;2018:4198673
pubmed: 30154686
Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):414-21
pubmed: 26475305
J Clin Oncol. 2015 Sep 10;33(26):2863-9
pubmed: 26240224
Blood. 2012 Jan 26;119(4):940-8
pubmed: 22160383
Blood. 2018 Jul 5;132(1):59-66
pubmed: 29784643
Leukemia. 2009 Jan;23(1):3-9
pubmed: 18971951
Oncol Lett. 2016 Mar;11(3):2255-2260
pubmed: 26998158
Br J Haematol. 2012 Dec;159(5):499-513
pubmed: 22881361
Haematologica. 2019 Sep;104(9):e420-e423
pubmed: 30765474
J Nucl Med. 2016 Jan;57(1):1-4
pubmed: 26541780
Haematologica. 2018 Jun;103(6):1047-1053
pubmed: 29567784
Clin Nucl Med. 2015 Jun;40(6):e300-7
pubmed: 25783508
Leukemia. 2006 Sep;20(9):1467-73
pubmed: 16855634
Lancet Oncol. 2017 Apr;18(4):e206-e217
pubmed: 28368259
Ann Hematol. 2020 Jan;99(1):127-135
pubmed: 31776725
J Nucl Med. 2013 May;54(5):683-90
pubmed: 23516309
Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1824-33
pubmed: 20505930
Blood. 2019 Feb 14;133(7):644-651
pubmed: 30587527
Am J Hematol. 2020 Aug;95(8):966-977
pubmed: 32350883
Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1046-53
pubmed: 21287167
Eur J Nucl Med Mol Imaging. 2018 May;45(5):712-719
pubmed: 29270787
Blood. 2011 Dec 1;118(23):5989-95
pubmed: 21900189
J Clin Oncol. 2021 Jan 10;39(2):116-125
pubmed: 33151787